PREVIOUS EVENTS

Dr. Blumsohn will discuss important ethical issues arising from the relationship between the pharmaceutical industry and universities. Who has ownership of, and rights of access to, data? How accountable for the final results are all the authors of scientific papers? Is it possible to spin the results of scientific experiments and data so that they look more acceptable? How ethical are the drugs regulators? How independent are medical journals? And where does this leave the patient?